
Development and manufacturing of non-invasive neurostimulators for auricular vagus nerve stimulation
XANA STIM Sàrl
Courroux (Switzerland Innovation Park, Basel Area – Jura Site) · Lausanne (Biopôle Park)New on Amplifa
About XANA STIM
XANA STIM Sàrl is a Swiss-Spanish neurotechnology company founded in 2016, headquartered at Switzerland Innovation Park Basel Area – Jura Site in Courroux and with a location in Biopôle Park in Lausanne. The company develops and manufactures intelligent, non-invasive neurostimulators, especially for stimulating the auricular vagus nerve. The core product is BODUS, a wearable neurostimulation platform with individualized, wireless earbuds, miniaturized electronics, multiple electrodes, and a PPG biosensor to measure heart rate variability. The therapy is controlled via a Mobile App; a cloud platform bundles therapy and data management and personalizes treatment using proprietary algorithms and measurement methods for efficacy assessment. The pipeline includes medical indications such as insomnia, migraine, stroke, heart failure, tinnitus, and depression. The company collaborates with clinics, research institutions, MedTech companies, and investors.
- Site
- Courroux
- Processes
- Development and manufacturing of non-invasive neurostimulators (auricular vagus nerve stimulation), Personalized therapy via Mobile App, Cloud-based therapy management and data management platform, Physiological monitoring (PPG sensor, HRV), Proprietary algorithms and measurement methods for efficacy assessment
- Materials
- Miniaturized Electronics, PPG Sensing, Cloud Platform & App
- Founded
- 2016
- Employees
- 2-10
- Industries
- Medical Technology, Neurotechnology, Digital Health, Healthcare, Wellness
- 01
Development of neurostimulation hardware
- 02
Manufacturing of miniaturized electronics
- 03
Individualized device customization
- 04
Mobile App & Cloud therapy management
- 05
Monitoring and efficacy assessment via algorithms
Technologies & Procedures
Miniaturized Electronics
Patented, miniaturized electronics control two electrodes and a biosensor in the wireless earbud.
PPG Sensing
Photoplethysmographic sensor records heart rate variability for objective therapy assessment.
Cloud Platform & App
Cloud-based therapy and data management personalizes treatment in real-time.
Locations

Courroux
CHHeadquarters (Switzerland Innovation Park, Basel Area – Jura Site)
- Materials
- Neurostimulation hardware, miniaturized electronics
Lausanne
CHLocation in Biopôle Park (Route de la Corniche 3)
Products & Components

Inside the production

Industries
Additional services
History
- 2016
Company founding (Launched January 2016)
- 2017
Grant from the European Commission (€50,000)
- 2019
Seed funding round of €260,000
- 2020
Seed funding round of €400,000
- 2021
Seed funding round of $512,000
- 2023
Seed funding round of CHF 1.0 Million